Lorraine Christie Porter
Director/Board Member at TCB Newco Ltd.
Profile
Lorraine Christie Porter was the founder of STATS Group Ltd., which was founded in 1998, where she held the title of Co-Managing Director.
Currently, she holds the position of Non-Executive Director at TCB Newco Ltd.
Lorraine Christie Porter active positions
Companies | Position | Start |
---|---|---|
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Director/Board Member | - |
Former positions of Lorraine Christie Porter
Companies | Position | End |
---|---|---|
STATS Group Ltd.
STATS Group Ltd. Oilfield Services/EquipmentIndustrial Services STATS Group Ltd. engages in the provision of pipeline-related solutions. It offers pressurised pipeline isolation, hot tapping and plugging services to the global oil, gas and petrochemical industries. The company was founded by Peter Alexander Duguid in 1998 and is headquartered in Kintore, the United Kingdom. | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
STATS Group Ltd.
STATS Group Ltd. Oilfield Services/EquipmentIndustrial Services STATS Group Ltd. engages in the provision of pipeline-related solutions. It offers pressurised pipeline isolation, hot tapping and plugging services to the global oil, gas and petrochemical industries. The company was founded by Peter Alexander Duguid in 1998 and is headquartered in Kintore, the United Kingdom. | Industrial Services |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
- Stock Market
- Insiders
- Lorraine Christie Porter